Erina Sakamoto

643 total citations
29 papers, 490 citations indexed

About

Erina Sakamoto is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Erina Sakamoto has authored 29 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Hematology. Recurrent topics in Erina Sakamoto's work include Lymphoma Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (4 papers) and Protein Degradation and Inhibitors (4 papers). Erina Sakamoto is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (4 papers) and Protein Degradation and Inhibitors (4 papers). Erina Sakamoto collaborates with scholars based in Japan and United States. Erina Sakamoto's co-authors include Masayuki Hino, Fumihiko Hato, Seiichi Kitagawa, Takayuki Kato, Fumio Tashiro, Hirotada Akiyama, Shigekazu Murakami, Tatsuhiro Shibata, Wataru Ninomiya and Haruo Kutsuna and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Oncogene.

In The Last Decade

Erina Sakamoto

28 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erina Sakamoto Japan 12 148 138 133 87 64 29 490
Milena Ivanova Bulgaria 14 123 0.8× 143 1.0× 361 2.7× 70 0.8× 56 0.9× 51 666
Liat Flaishon Israel 12 121 0.8× 105 0.8× 407 3.1× 105 1.2× 35 0.5× 20 670
Fatima Dhalla United Kingdom 14 105 0.7× 210 1.5× 439 3.3× 78 0.9× 88 1.4× 20 794
Gabrielle Carvalho France 11 77 0.5× 206 1.5× 190 1.4× 49 0.6× 35 0.5× 13 511
Alicia D. Volkheimer United States 14 108 0.7× 254 1.8× 373 2.8× 165 1.9× 58 0.9× 30 801
Barbara Pietrucha Poland 12 81 0.5× 283 2.1× 152 1.1× 36 0.4× 60 0.9× 43 556
Huiting Su China 12 122 0.8× 195 1.4× 240 1.8× 43 0.5× 95 1.5× 24 589
Kakushi Matsushita Japan 17 103 0.7× 104 0.8× 486 3.7× 47 0.5× 44 0.7× 55 771
Geoffrey O. Gillard United States 16 122 0.8× 217 1.6× 562 4.2× 46 0.5× 70 1.1× 20 913
Deborah L. Burnett Australia 10 59 0.4× 186 1.3× 323 2.4× 56 0.6× 47 0.7× 19 568

Countries citing papers authored by Erina Sakamoto

Since Specialization
Citations

This map shows the geographic impact of Erina Sakamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erina Sakamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erina Sakamoto more than expected).

Fields of papers citing papers by Erina Sakamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erina Sakamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erina Sakamoto. The network helps show where Erina Sakamoto may publish in the future.

Co-authorship network of co-authors of Erina Sakamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Erina Sakamoto. A scholar is included among the top collaborators of Erina Sakamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erina Sakamoto. Erina Sakamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshida, Masahiro, Takafumi Nakao, Takeshi Inoue, et al.. (2015). Analysis of elderly patients with diffuse large B‐cell lymphoma: aggressive therapy is a reasonable approach for ‘unfit’ patients classified by comprehensive geriatric assessment. European Journal Of Haematology. 96(4). 409–416. 28 indexed citations
2.
Hirai, Manabu, et al.. (2015). Azacitidine (AZA) Combination Therapy with Low-Dose AraC for Aggressive Type MDS, Overt AML, and AML Patients. Blood. 126(23). 1688–1688. 1 indexed citations
3.
Murakami, Shigekazu, Wataru Ninomiya, Erina Sakamoto, et al.. (2015). SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy Targets. Stem Cells. 33(9). 2652–2663. 68 indexed citations
4.
Murakami, Tomoaki, Yasuo Inoshima, Erina Sakamoto, et al.. (2013). AA Amyloidosis in Vaccinated Growing Chickens. Journal of Comparative Pathology. 149(2-3). 291–297. 25 indexed citations
5.
Murakami, Shigekazu, Erina Sakamoto, Tsugumichi Sato, et al.. (2013). The male-specific factor Sry harbors an oncogenic function. Oncogene. 33(23). 2978–2986. 26 indexed citations
6.
Manabe, Masahiro, Yoshiki Hayashi, Satoru Mukai, et al.. (2012). Primary diffuse large B-Cell lymphoma of the prostate presenting with urinary retention and dyschezia for which rituximab-combined CHOP therapy was effective-a case presentation.. PubMed. 39(11). 1733–5. 2 indexed citations
7.
Koh, Hideo, Takahiko Nakane, Erina Sakamoto, et al.. (2012). Serum Cytokine Profiles in Hemophagocytic Syndrome following Allogeneic Hematopoietic Stem Cell Transplantation. Acta Haematologica. 127(3). 182–185. 6 indexed citations
8.
Tomita, Jun, et al.. (2011). High calorie diet augments age-associats sleep impairment in Drosophila. Biochemical and Biophysical Research Communications. 417(2). 812–816. 25 indexed citations
9.
Manabe, Masahiro, Satoru Mukai, Erina Sakamoto, et al.. (2010). Extramedullary plasmacytoma of the dura mimicking meningioma. International Journal of Hematology. 91(5). 731–732. 7 indexed citations
10.
Ohta, Kensuke, Yoshitaka Nakao, Erina Sakamoto, et al.. (2009). Efficacy and safety of intravenous itraconazole as empirical antifungal therapy for persistent fever in neutropenic patients with hematological malignancies in Japan. International Journal of Hematology. 89(5). 649–655. 6 indexed citations
11.
12.
Terada, Yoshiki, Hirohisa Nakamae, Erina Sakamoto, et al.. (2009). Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma. Journal of Experimental & Clinical Cancer Research. 28(1). 116–116. 49 indexed citations
13.
14.
Terada, Yoshiki, Hirohisa Nakamae, Erina Sakamoto, et al.. (2008). The Impact of Relative Dose Intensity of Rituximab-CHOP on Survival in Diffuse Large B-Cell Lymphoma Patients. Blood. 112(11). 4931–4931. 3 indexed citations
15.
Nakamae, Mika, Hirohisa Nakamae, Erina Sakamoto, et al.. (2007). Two Cases of Ampulla (Takotsubo-Shaped) Cardiomyopathy Associated with Hemophagocytic Lymphohistiocytosis. Acta Haematologica. 117(4). 205–210. 11 indexed citations
16.
17.
Kato, Takayuki, Sayuri Masuda, Erina Sakamoto, et al.. (2006). Enhanced neutrophil motility by granulocyte colony‐stimulating factor: the role of extracellular signal‐regulated kinase and phosphatidylinositol 3‐kinase. Immunology. 119(3). 393–403. 33 indexed citations
18.
Hirose, Asao, Takahisa Yamane, Y. Nakajima, et al.. (2005). [Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma].. PubMed. 32(13). 2059–64. 1 indexed citations
19.
Kato, Takayuki, et al.. (2004). Proteolytic Conversion of STAT3α to STAT3γ in Human Neutrophils. Journal of Biological Chemistry. 279(30). 31076–31080. 36 indexed citations
20.
Hato, Fumihiko, Noriko Kamata, Erina Sakamoto, et al.. (2004). Selective activation of STAT3 in human monocytes stimulated by G-CSF: implication in inhibition of LPS-induced TNF-α production. American Journal of Physiology-Cell Physiology. 286(6). C1302–C1311. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Milena Ivanova Breakdown of academic impact, for papers by Liat Flaishon Breakdown of academic impact, for papers by Fatima Dhalla Breakdown of academic impact, for papers by Gabrielle Carvalho Breakdown of academic impact, for papers by Alicia D. Volkheimer Breakdown of academic impact, for papers by Barbara Pietrucha Breakdown of academic impact, for papers by Huiting Su Breakdown of academic impact, for papers by Kakushi Matsushita Breakdown of academic impact, for papers by Geoffrey O. Gillard Breakdown of academic impact, for papers by Deborah L. Burnett
Rankless by CCL
2026